<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The hereditary <z:hpo ids='HP_0001258'>spastic paraplegias</z:hpo> (<z:chebi fb="24" ids="50430">HSPs</z:chebi>) are a clinically and genetically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorders</z:e> characterised by <z:hpo ids='HP_0002061'>lower limb spasticity</z:hpo> and <z:mp ids='MP_0000746'>weakness</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations in NIPA1 (Nonimprinted in Prader-Willi/<z:e sem="disease" ids="C0162635" disease_type="Disease or Syndrome" abbrv="">Angelman syndrome</z:e> 1) have recently been identified as a cause of <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> pure <z:chebi fb="24" ids="50430">HSP</z:chebi>, with one mutation described in two unrelated families </plain></SENT>
<SENT sid="2" pm="."><plain>NIPA1 has no known function but is predicted to possess nine transmembrane domains and may function as a receptor or transporter </plain></SENT>
<SENT sid="3" pm="."><plain>Here we present a large British pedigree in which linkage analysis conclusively demonstrates linkage to the NIPA1 locus (maximum multipoint LOD score 4.6) </plain></SENT>
<SENT sid="4" pm="."><plain>Subsequent mutation analysis identified a novel missense substitution in a highly conserved NIPA1 residue (G106R) which further confirms a causative link between NIPA1 mutation and <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> hereditary <z:hpo ids='HP_0001258'>spastic paraplegia</z:hpo> </plain></SENT>
</text></document>